- Home
- CMTL vs RGLS Comparison
CMTL vs RGLS Comparison
Compare CMTL & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- RGLS
- Stock Information
- Founded
- CMTL 1967
- RGLS 2007
- Country
- CMTL United States
- RGLS United States
- Employees
- CMTL N/A
- RGLS N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- RGLS Health Care
- Exchange
- CMTL Nasdaq
- RGLS Nasdaq
- Market Cap
- CMTL 97.9M
- RGLS 102.1M
- IPO Year
- CMTL N/A
- RGLS 2012
- Fundamental
- Price
- CMTL $3.51
- RGLS $1.60
- Analyst Decision
- CMTL Strong Buy
- RGLS Strong Buy
- Analyst Count
- CMTL 1
- RGLS 6
- Target Price
- CMTL $9.25
- RGLS $10.33
- AVG Volume (30 Days)
- CMTL 363.6K
- RGLS 261.9K
- Earning Date
- CMTL 12-24-2024
- RGLS 11-07-2024
- Dividend Yield
- CMTL N/A
- RGLS N/A
- EPS Growth
- CMTL N/A
- RGLS N/A
- EPS
- CMTL N/A
- RGLS N/A
- Revenue
- CMTL $540,403,000.00
- RGLS N/A
- Revenue This Year
- CMTL $0.96
- RGLS N/A
- Revenue Next Year
- CMTL $10.66
- RGLS N/A
- P/E Ratio
- CMTL N/A
- RGLS N/A
- Revenue Growth
- CMTL N/A
- RGLS N/A
- 52 Week Low
- CMTL $1.53
- RGLS $1.08
- 52 Week High
- CMTL $8.71
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- CMTL 53.48
- RGLS 52.02
- Support Level
- CMTL $2.73
- RGLS $1.53
- Resistance Level
- CMTL $3.77
- RGLS $1.70
- Average True Range (ATR)
- CMTL 0.30
- RGLS 0.10
- MACD
- CMTL -0.01
- RGLS 0.00
- Stochastic Oscillator
- CMTL 61.52
- RGLS 35.19
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.